DAP

DANAHER CORP. DL-,01

Stock XETRA – Stock Market Prices, News & Analysis

Danaher est un conglomérat américain spécialisé dans les médicales, l'analyse scientifique, et les solutions environnementales innovantes.

€ 155.45
1.01 %

DANAHER CORP. DL-,01

155.45
1.01 %
DAP

Danaher est un conglomérat américain spécialisé dans les médicales, l'analyse scientifique, et les solutions environnementales innovantes.

Price history of DANAHER CORP. DL-,01
Price history of DANAHER CORP. DL-,01

Performance & Momentum

6 Months 20.08 %
1 Year 11.77 %
3 Years 16.99 %
5 Years

Strategic Analysis

DANAHER CORP. DL-,01 • 2026

Danaher is positioned as a global leader in medical and scientific analytics, built on an integrated model combining technological innovation and sector diversification. Its ability to develop high-value solutions in complex technological niches gives it a durable competitive advantage.

Strengths
  • Diversified portfolio spanning healthcare, scientific analytics, and environmental solutions
  • Strong focus on technological innovation and cutting-edge applications
  • Solid international positioning with a significant presence in the U.S. market
Weaknesses
  • Short- and medium-term stock performance has lagged, reflecting operational or cyclical challenges
  • Exposure to sectors where technological competition is intense and requires ongoing investment
Momentum

Current momentum reflects persistent downward pressure on the stock, suggesting a difficult environment for the sector in which Danaher operates. Any investor will need to closely monitor the evolution of innovation catalysts and operating results to identify a potential turnaround.

Similar stocks to DANAHER CORP. DL-,01

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone